Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Verma

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Archives of Dermatological Research|November 30, 2024
Total-body skin examination prevalence among individuals with risk factors for skin cancer by insurance type: a National Health Interview Survey studyHannah Verma, Annie Chang, Jeremy Orloff, et al.
JAAD Case Reports|April 14, 2025
Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinomaRaphaella Lambert, Scott Stratman, Grace Rabinowitz, et al.
JAAD Case Reports|December 13, 2023
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life studyJade N Young, Hannah Verma, Nour El Kashlan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 14, 2024
Patch Testing Results From the Icahn School of Medicine at Mount Sinai Department of Dermatology 2017-2021Sabrina Ghalili, Margaret Downes, Eden David, et al.
Clinical and Experimental Dermatology|October 30, 2024
Changes in patient sentiment on Reddit through periods of atopic dermatitis treatmentAndrew K Yang, Camille M Powers, Hannah Verma, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2023
Individual and sociodemographic factors associated with polysensitization at a New York City hospitalSabrina Ghalili, Margaret Downes, Ross O'Hagan, et al.
JAAD Case Reports|January 19, 2026
Response of recalcitrant Blaschkoid psoriasis to bimekizumab: A case reportHannah Verma, Marguerite Meariman, Benjamin Gerstein, et al.
Journal of the American Academy of Dermatology|March 16, 2026
Topical ruxolitinib for localized, steroid-refractory cutaneous immune-related adverse events: A single-institution real-world studyBrandon R Block, Jaanvi Mehta, Kateryna Karpoff, et al.
Facial Plastic Surgery : FPS|August 27, 2024
Rhytidectomy Incision Techniques and Scar Outcomes: A Scoping ReviewKatherine Y Liu, David W Chou, Hannah Verma, et al.
Journal of the American Academy of Dermatology|December 1, 2025
Rural-urban disparities in the use of biologics and nonsteroidal topicals for inflammatory dermatologic conditions: A DataDerm studyBrandon R Block, Raphaella A Lambert, Jade N Young, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Archives of Dermatological Research|November 30, 2024
Total-body skin examination prevalence among individuals with risk factors for skin cancer by insurance type: a National Health Interview Survey studyHannah Verma, Annie Chang, Jeremy Orloff, et al.
JAAD Case Reports|April 14, 2025
Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinomaRaphaella Lambert, Scott Stratman, Grace Rabinowitz, et al.
JAAD Case Reports|December 13, 2023
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life studyJade N Young, Hannah Verma, Nour El Kashlan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 14, 2024
Patch Testing Results From the Icahn School of Medicine at Mount Sinai Department of Dermatology 2017-2021Sabrina Ghalili, Margaret Downes, Eden David, et al.
Clinical and Experimental Dermatology|October 30, 2024
Changes in patient sentiment on Reddit through periods of atopic dermatitis treatmentAndrew K Yang, Camille M Powers, Hannah Verma, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2023
Individual and sociodemographic factors associated with polysensitization at a New York City hospitalSabrina Ghalili, Margaret Downes, Ross O'Hagan, et al.
JAAD Case Reports|January 19, 2026
Response of recalcitrant Blaschkoid psoriasis to bimekizumab: A case reportHannah Verma, Marguerite Meariman, Benjamin Gerstein, et al.
Journal of the American Academy of Dermatology|March 16, 2026
Topical ruxolitinib for localized, steroid-refractory cutaneous immune-related adverse events: A single-institution real-world studyBrandon R Block, Jaanvi Mehta, Kateryna Karpoff, et al.
Facial Plastic Surgery : FPS|August 27, 2024
Rhytidectomy Incision Techniques and Scar Outcomes: A Scoping ReviewKatherine Y Liu, David W Chou, Hannah Verma, et al.
Journal of the American Academy of Dermatology|December 1, 2025
Rural-urban disparities in the use of biologics and nonsteroidal topicals for inflammatory dermatologic conditions: A DataDerm studyBrandon R Block, Raphaella A Lambert, Jade N Young, et al.
Pageof 4